Amgen's Improving Balance Sheet Signals Potential Buy Opportunity
Published on December 13, 2025
Amgen Inc. (AMGN) has been gaining positive attention from analysts lately, with BMO Capital raising its price target due to the strong outlook for its MariTide platform. Additionally, Wells Fargo maintains its Equal-Weight recommendation for the company, noting the potential for growth. Bank of Nova Scotia has also shown confidence in Amgen, holding a significant stake in the company. With the balance sheet continuing to improve, experts are considering Amgen a potential buy opportunity. For more insights on the movement of Amgen's stock, consult the professionals at Stocks Prognosis.
Investor opinions & comments
To leave a comment, you need to Login or Register.
HenryMurphy
December 16, 2025 at 07:36
I recommend considering Amgen for investment, the positive outlook is encouraging
DanielTaylor
December 15, 2025 at 15:06
The stake from Bank of Nova Scotia is interesting, but I'm cautious about the overall market conditions
SavingsSamantha
December 15, 2025 at 13:41
I'm hesitant to jump in without further analysis, the potential growth needs to be validated
WealthyWanda
December 15, 2025 at 10:05
Spannende Nachricht, werde mir Amgen genauer anschauen
FinanceFelix
December 15, 2025 at 05:50
I'm not convinced yet, need to see more data before considering Amgen
DividendDiane
December 14, 2025 at 12:32
Amgen's momentum looks strong, I'm optimistic about its future performance
ProfitPam
December 13, 2025 at 18:14
With the improving balance sheet and positive analyst reviews, Amgen looks like a solid choice for investment
PennyParker
December 13, 2025 at 15:22
Sounds like a promising opportunity, I'll definitely keep an eye on Amgen
MeganThompson
December 13, 2025 at 10:57
Excited to see Amgen's balance sheet improving, this could be a great buying opportunity